[HTML][HTML] Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas, DN Edwards… - Journal of …, 2019 - Springer
Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
Interleukin 1 Alpha Administration Is Neuroprotective and Neuro-Restorative Following Experimental Ischemic Stroke
KE Salmeron, ME Maniskas, DN Edwards… - Journal of … - uknowledge.uky.edu
BACKGROUND: Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.
KE Salmeron, ME Maniskas… - Journal of …, 2019 - search.ebscohost.com
Abstract < bold> Background: </bold> Stroke remains a leading cause of death and
disability worldwide despite recent treatment breakthroughs. A primary event in stroke …
disability worldwide despite recent treatment breakthroughs. A primary event in stroke …
[HTML][HTML] Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas… - Journal of …, 2019 - jneuroinflammation.biomedcentral …
Stroke remains a leading cause of death and disability worldwide despite recent treatment
breakthroughs. A primary event in stroke pathogenesis is the development of a potent and …
breakthroughs. A primary event in stroke pathogenesis is the development of a potent and …
Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.
KE Salmeron, ME Maniskas, DN Edwards… - Journal of …, 2019 - go.gale.com
Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke.
KE Salmeron, ME Maniskas, DN Edwards… - Journal of …, 2019 - europepmc.org
Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas… - Journal of …, 2019 - research.manchester.ac.uk
Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas, DN Edwards… - Journal of …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Stroke remains a leading cause of death and disability worldwide despite recent treatment …
Stroke remains a leading cause of death and disability worldwide despite recent treatment …
[PDF][PDF] Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas, DN Edwards, R Wong… - 2019 - academia.edu
Background: Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
[HTML][HTML] Interleukin 1 alpha administration is neuroprotective and neuro-restorative following experimental ischemic stroke
KE Salmeron, ME Maniskas, DN Edwards… - Journal of …, 2019 - ncbi.nlm.nih.gov
Background Stroke remains a leading cause of death and disability worldwide despite
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …
recent treatment breakthroughs. A primary event in stroke pathogenesis is the development …